Centre for Health Economics
In June 2019 we focused on MARC members in the Centre for Health Economics.
The Centre for Health Economics (CHE) is one of the largest independent groups of health economists in Australia. They are recognised as one of the leading centres in health economics research and education, both in Australia and internationally. Some of their past collaborations include working with the World Health Organisation (WHO), Organisation for Economic Cooperation and Development (OECD), and Harvard and Stanford Universities. The centre has made significant contributions to public policy and health services including working with the Pharmaceutical Benefits and Medical Services Advisory Committees.
One major research area at CHE is risky behaviour, including illicit drug use, excessive consumption of alcohol and prescription drugs, smoking, gambling, unsafe sex, dangerous driving practices and also poor diet and physical inactivity. MARC members Dr Sonja Kassenboehmer and A/ Professor Dennis Petrie are both based at the CHE. Their current research seeks to understand the drivers of the increase in opioid deaths in Australia and which policy measures truly work and for whom. A specific focus is on the causal evaluation of both intended and unintended effects of recent supply- and demand-side interventions for pharmaceutical drugs to suggest new policies to curb the high rates of opioid use disorder and associated deaths.
Read more about Dr Sonja Kassenboehmer's work here.
Read more about A/Prof Dennis Petrie's work here.